Your browser doesn't support javascript.
loading
Molecular diagnostic assays for the detection of common bacterial meningitis pathogens: A narrative review.
Diallo, Kanny; Feteh, Vitalis F; Ibe, Lilian; Antonio, Martin; Caugant, Dominique A; du Plessis, Mignon; Deghmane, Ala-Eddine; Feavers, Ian M; Fernandez, Katya; Fox, LeAnne M; Rodrigues, Charlene M C; Ronveaux, Olivier; Taha, Muhamed-Kheir; Wang, Xin; Brueggemann, Angela B; Maiden, Martin C J; Harrison, Odile B.
Afiliación
  • Diallo K; Department of Zoology, University of Oxford, South Parks Rd, Oxford OX1 3SY, United Kingdom; Centre Suisse de Recherches Scientifiques en Côte d'Ivoire, Abidjan, Cote d'Ivoire.
  • Feteh VF; Department of Zoology, University of Oxford, South Parks Rd, Oxford OX1 3SY, United Kingdom; Nuffield Department of Population Health, Big Data Institute, University of Oxford, Oxford OX3 7LF, United Kingdom.
  • Ibe L; Department of Zoology, University of Oxford, South Parks Rd, Oxford OX1 3SY, United Kingdom; Nuffield Department of Population Health, Big Data Institute, University of Oxford, Oxford OX3 7LF, United Kingdom.
  • Antonio M; WHO Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Atlantic Boulevard, Fajara, PO Box 273, Banjul, Gambia; Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of
  • Caugant DA; WHO Collaborating Center for Reference and Research on Meningococci, Norwegian Institute of Public Health, Oslo N-0213, Norway.
  • du Plessis M; A division of the National Health Laboratory Service (NHLS), National Institute for Communicable Diseases (NICD), Johannesburg, South Africa.
  • Deghmane AE; Institut Pasteur, 25-28 Rue du Dr Roux, Paris 75015, France.
  • Feavers IM; Department of Zoology, University of Oxford, South Parks Rd, Oxford OX1 3SY, United Kingdom.
  • Fernandez K; WHO Infectious Hazard Management, Geneva, Switzerland.
  • Fox LM; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Division of Bacterial Diseases, Meningitis and Vaccine Preventable Diseases Branch, United States.
  • Rodrigues CMC; Department of Zoology, University of Oxford, South Parks Rd, Oxford OX1 3SY, United Kingdom; Department of Paediatric Infectious Diseases, St George's University Hospitals NHS Foundation Trust, London, United Kingdom.
  • Ronveaux O; WHO Infectious Hazard Management, Geneva, Switzerland.
  • Taha MK; Institut Pasteur, 25-28 Rue du Dr Roux, Paris 75015, France.
  • Wang X; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Division of Bacterial Diseases, Meningitis and Vaccine Preventable Diseases Branch, United States.
  • Brueggemann AB; Nuffield Department of Population Health, Big Data Institute, University of Oxford, Oxford OX3 7LF, United Kingdom.
  • Maiden MCJ; Department of Zoology, University of Oxford, South Parks Rd, Oxford OX1 3SY, United Kingdom.
  • Harrison OB; Department of Zoology, University of Oxford, South Parks Rd, Oxford OX1 3SY, United Kingdom. Electronic address: odile.harrison@zoo.ox.ac.uk.
EBioMedicine ; 65: 103274, 2021 Mar.
Article en En | MEDLINE | ID: mdl-33721818
ABSTRACT
Bacterial meningitis is a major global cause of morbidity and mortality. Rapid identification of the aetiological agent of meningitis is essential for clinical and public health management and disease prevention given the wide range of pathogens that cause the clinical syndrome and the availability of vaccines that protect against some, but not all, of these. Since microbiological culture is complex, slow, and often impacted by prior antimicrobial treatment of the patient, molecular diagnostic assays have been developed for bacterial detection. Distinguishing between meningitis caused by Neisseria meningitidis (meningococcus), Streptococcus pneumoniae (pneumococcus), Haemophilus influenzae, and Streptococcus agalactiae and identifying their polysaccharide capsules is especially important. Here, we review methods used in the identification of these bacteria, providing an up-to-date account of available assays, allowing clinicians and diagnostic laboratories to make informed decisions about which assays to use.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Meningitis Bacterianas Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: EBioMedicine Año: 2021 Tipo del documento: Article País de afiliación: Costa de Marfil

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Meningitis Bacterianas Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: EBioMedicine Año: 2021 Tipo del documento: Article País de afiliación: Costa de Marfil